Uncategorized
Senate committee proposes more efficient approval of medical devices
The U.S. Senate Committee on Health, Education, Labor and Pensions favorably reported legislation that would streamline the FDA’s evaluation process for medical devices, one of seven biomedical innovation bills currently advancing to the full Senate for consideration.The FDA Device Accountability Act of 2015 (S. 1622), sponsored by Sens. Richard Burr, R-N.C., and Al Franken, D-Minn., and co-sponsored by Mark Kirk, R-Ill., is intended to ensure the “least burdensome means” of evaluating medical devices, according to the bill’s authors.